Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT01377220
Eligibility Criteria:
Inclusion Criteria:
* Patients up to 18 years old with
* Patients with suspicion hepatocellular carcinoma on conventional imaging(hepatic ultrasonography, abdominal computed tomography, dynamic resonance magnetic)and/or on alpha fetoprotein measurement
* Patients with suspicion recurrence of hepatocellular carcinoma on conventional imaging(hepatic ultrasonography, abdominal computed tomography, dynamic resonance magnetic)and/or on alpha fetoprotein measurement
* Patients which perform two conventional imaging techniques, consisting in dynamic magnetic resonance imaging (MRI) and computed tomography (CT)and must have an alpha fetoprotein measurement
* Patients which perform 18F-FDG PET-CT
* Informed Consent Form signed and dated by patients
* Patients which are "Security Social" affiliated
Exclusion Criteria:
* Pregnant or suckling women
* Women able to procreate, without efficient birth control
* Patients with an other tumoral disease
* Patients with chemotherapy or surgery from less than four weeks
* Patients with radiotherapy from less four months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01377220
Study Brief:
Protocol Section:
NCT01377220